FORTREA EXPANDS EXECUTIVE TEAM FOR CLINICAL DEVELOPMENT, DEEPENS CLIENT PARTNERSHIPS
KUALA LUMPUR, Feb 23 (Bernama) -- Fortrea, a global contract research organisation (CRO), has strengthened its executive leadership with Oren Cohen and Scott Dove. Cohen, who previously served as both Fortrea’s Chief Medical Officer (CMO) and President of Clinical Pharmacology Services (CPS), will now focus exclusively on his CMO responsibilities, overseeing medical strategy, scientific leadership, and governance across Fortrea’s portfolio. Meanwhile, Dove joins Fortrea as the new President of CPS, responsible for the company’s early clinical development solutions across its global network of clinical research units. Both Cohen and Dove will serve on Fortrea’s Executive Committee. Fortrea Chief Executive Officer, Anshul Thakral said the addition of Dove to the Fortrea team while Cohen becomes fully dedicated to the medical and scientific aspects of development is a win for clients. “Oren will deepen his relationships with clients across all phases of clinical development, while Scott i...
